BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 38745196)

  • 1. Critical role of the gut microbiota in immune responses and cancer immunotherapy.
    Li Z; Xiong W; Liang Z; Wang J; Zeng Z; Kołat D; Li X; Zhou D; Xu X; Zhao L
    J Hematol Oncol; 2024 May; 17(1):33. PubMed ID: 38745196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
    Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
    Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
    Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
    Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.
    Pandey P; Khan F
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130401. PubMed ID: 37307905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer and immunotherapy: a role for microbiota composition.
    Pham F; Moinard-Butot F; Coutzac C; Chaput N
    Eur J Cancer; 2021 Sep; 155():145-154. PubMed ID: 34375896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
    Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
    Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intimate relationship between gut microbiota and cancer immunotherapy.
    Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
    Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Gut Microbiota-Derived Metabolites on Immune Checkpoint Inhibitor Therapy: Enemy or Friend?
    Zhao H; Wang D; Zhang Z; Xian J; Bai X
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges.
    Bouferraa Y; Chedid A; Amhaz G; El Lakkiss A; Mukherji D; Temraz S; Shamseddine A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
    Hou X; Zheng Z; Wei J; Zhao L
    Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota.
    Frankel AE; Deshmukh S; Reddy A; Lightcap J; Hayes M; McClellan S; Singh S; Rabideau B; Glover TG; Roberts B; Koh AY
    Integr Cancer Ther; 2019; 18():1534735419846379. PubMed ID: 31014119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors.
    Wang J; Zhu N; Su X; Yang R
    Cancer Lett; 2024 Feb; 582():216582. PubMed ID: 38065401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
    Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
    J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome and cancer immunotherapy.
    Sun JY; Yin TL; Zhou J; Xu J; Lu XJ
    J Cell Physiol; 2020 May; 235(5):4082-4088. PubMed ID: 31663125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota: A key factor affecting and regulating the efficacy of immunotherapy.
    Jiang Y; Jia D; Sun Y; Ding N; Wang L
    Clin Transl Med; 2023 Dec; 13(12):e1508. PubMed ID: 38082435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the emerging role of the microbiome in cancer immunotherapy.
    Fessler J; Matson V; Gajewski TF
    J Immunother Cancer; 2019 Apr; 7(1):108. PubMed ID: 30995949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.